NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/06/2026
Back to search
Official data from USPTO
REGENERIS MEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
01/06/2026
Classification
Registered
Trademark type
Combined
Nice classes
44
Filing date
04/07/2024
Registration date
01/06/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/06/2026
Last transaction
01/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/15/2015
First use in commerce
07/15/2015
Drawing code
3
Owner type
01
Owner location
North Attleboro, MA
Examiner
WOOD,CAROLINE
Law office
M10
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of A leaf, DNA image and two words: Regeneris Medical.
Holders and representatives
Holders
Ryan Welter, MD, PhD
Juliette Jane Safety, LLC
Representatives
Daniel Saam CopyMark Law Group, LLC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Cosmetic and plastic surgery; Medical services relating to the removaltreatment and processing of stem cells; Regenerative medicine services
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/06/2026
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
12/11/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
06/26/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/03/2025
PUBO
PUBLISHED FOR OPPOSITION
06/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/28/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/07/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/07/2025
GNRT
NON-FINAL ACTION E-MAILED
02/07/2025
CNRT
NON-FINAL ACTION WRITTEN
02/07/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/10/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/10/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/28/2024
GNRT
NON-FINAL ACTION E-MAILED
10/28/2024
CNRT
NON-FINAL ACTION WRITTEN
10/28/2024
DOCK
ASSIGNED TO EXAMINER
10/21/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/13/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/13/2024
NWAP
NEW APPLICATION ENTERED
04/07/2024
Continuous trademark protection
Get notified about every new filing that threatens REGENERIS MEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.